Status:
UNKNOWN
Infectious Prospective Collection for Biological Analysis
Lead Sponsor:
CerbaXpert
Conditions:
Infectious Disease
Eligibility:
All Genders
18-88 years
Brief Summary
The increase in activity within medical biology laboratories linked to the arrival of new markers (in cardiology, oncology, infectious diseases, etc.) and the acceleration of technical progress have c...
Detailed Description
This research protocol is a prospective multicenter collection of biological samples for evaluation of reagents and automated systems on the following parameters: HAV, B, C, D and E, HIV, HBV, EBV, CM...
Eligibility Criteria
Inclusion
- All-comers clinical subjects (ambulatory)
- Hospitalized patients
- Pregnant women (all comers)
- Subjects on dialysis
- Known subjects positive for targeted pathogens
Exclusion
- Subject having already participated in this protocol within 15 days previous ones.
- Subject having received medication or treatment experimental or investigational during the last four weeks before collection
- Person subject to a judicial safeguard measure
- Person not affiliated to the Social Security system and not not having social security coverage
- Person not meeting the inclusion criteria
Key Trial Info
Start Date :
May 18 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
May 18 2025
Estimated Enrollment :
22870 Patients enrolled
Trial Details
Trial ID
NCT06159270
Start Date
May 18 2019
End Date
May 18 2025
Last Update
December 6 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cerba Xpert
Saint-Ouen-l'Aumône, France